Jianfeng Group Lin2017 -013 (Announcement of Resolution of the 13th Session of the 9th Board of Directors)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-013
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Ninth Session 13 Board Resolution Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the company's "Articles of Association.
(II) 2017# On May 31, the company issued the notice of the board meeting by fax, e-mail and personal delivery.
(III) 2017# On June 6, 34, the board meeting was held by means of communication voting.(IV) 9
directors who should attend the board meeting, 9 directors who actually attended the meeting, and 9 valid votes at the meeting.2. Board Meeting Deliberations
1
, Passed "Proposal on Leasing Peak International Trade Warehouse"The Board of Directors deliberated and passed the proposal. It is agreed that the holding subsidiary Zhejiang Jianfeng International Trade Co., Ltd. (hereinafter referred to as "Jianfeng International Trade") will lease the warehouse, storage yard, parking lot and other properties in its "New Warehouse (E-commerce Logistics Park) Project" (see the announcement of the 11th resolution of the 9th session of Jianfeng Group 2017-006 disclosed on April 18, 2017
) to Shanghai Aneng Juchuang Supply Chain Management Co., Ltd, the planning and design area of the leased warehouse is about 37248 square meters (subject to actual delivery in the end), and the lease period is 5 years after the project is completed and delivered; the project is currently under planning and design, and the construction period is expected to be 6 months. If the project can be completed and delivered on schedule, the rent for the first full year (12 months) is about 13 million yuan, and it will increase by 3% every year thereafter. It is agreed that Jianfeng International Trade will entrust the above-mentioned leased property to Jinhua Cheng Rui Information Consulting Service Co., Ltd. for management. Jianfeng International Trade will have to pay a property management fee of about 2.68 million yuan per year.Voting result: 9
votes in favor, 0 votes against, 0 abstentions.2
, passed the "Proposal on Adding Members to Special Committees of the Board of Directors"The Board of Directors deliberated and passed the proposal.
agreed to appoint Mr. Sun Hongbin as a member of the strategy committee and nomination committee of the ninth board of directors of the company, and as the chairman of the nomination committee; Mr. Huang Sujian was appointed as a member of the strategy committee of the ninth board of directors of the company. The term of office is consistent with the current Board of Directors.
voting result: 9
votes in favor, 0 votes against, 0 abstentions.hereby announces
Zhejiang Jianfeng Group Co., Ltd.
Board of DirectorsJune 6, 2017
Annex:
Resume of Mr. Sun Hongbin: 1966
Born in December 76, Doctor of Science, Distinguished Professor of "Changjiang Scholar" of the Ministry of Education. He has successively engaged in post-doctoral research in Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Aachen University of Technology in Germany and University of Florida in the United States, and engaged in new drug research in California Metabolex Company in the United States. He is currently a professor, doctoral supervisor, and director of the New Drug Research Center of China Pharmaceutical University, director of Jiangsu Provincial Key Laboratory of Metabolic Diseases, Deputy Director of State Key Laboratory of "Natural Drug Active Components and Efficacy", Member of Medicinal Chemistry Professional Committee of Chinese Pharmaceutical Association, Deputy Chairman of Medicinal Chemistry Professional Committee of Jiangsu Pharmaceutical Association, Member of Degree Evaluation Committee and Academic Committee of China Pharmaceutical University, Deputy Leader of the "Thirteenth Five-Year" Development Strategy Research "Pharmacology" Expert Group of the Medical Department of the National Fund Committee, National Technology Invention Award Meeting Review Expert, Honorary Jiangsu Weikair chairman, etc.Resume of Mr. Huang Sujian: Born in November 1955
, PhD in Economics, researcher, worked in the Institute of Industrial Economics of the Chinese Academy of Social Sciences from February 1988 to April 2016, and served as the Institute of Industrial Economics of the Chinese Academy of Social Sciences Deputy director and director of the company. He is currently a researcher at the Institute of Industrial Economics of the Chinese Academy of Social Sciences and the president of the China Enterprise Management Research Association. He is also an independent director of Inner Mongolia Yitai Coal Co., Ltd.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31